Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Q1 2024 Twist Bioscience Corp Earnings Call Transcript

Feb 02, 2024 / 01:00PM GMT
Release Date Price: €32 (+7.38%)
Operator

Welcome to Twist Bioscience's fiscal 2024 First Quarter financial results conference call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question and answer session. Instructions will be given at that time. I would like to turn the conference over to Angela Bitting, Senior Vice President of Corporate Affairs.

Angela Bitting
Twist Bioscience Corporation - SVP, Corporate Affairs & Chief ESG Officer

Thank you, operator. Good morning, everyone. I'd like to thank all of you for joining us today for Twist Biosciences conference call to review our fiscal 2024 first quarter financial results and business progress. We issued our financial results release this morning, which is available at our website at www.twistbioscience.com.

With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist, and Adam laponis, CFO. Emily will begin with a review of our recent progress on twist businesses. Adam will report on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot